Remote monitoring for managing chronic respiratory diseases like asthma
Official title: Remote Patient Monitoring Solution for Chronic Respiratory Disease Management
Run by SingHealth Polyclinics · NCT06377345 · Data updated 2026-11-12
This study is testing if a new remote monitoring system can help people with asthma manage their symptoms better and reduce the number of asthma attacks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years to 90 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | SingHealth Polyclinics Academic / other |
| Locations | 1 site (Singapore) |
| Status | Recruiting |
| Started | May 1, 2024 |
| Main results expected | September 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | May 15, 2025 |
| Trial ID | NCT06377345 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pediatric patients aged 7 to 17 and adults aged 18 and above who have a diagnosis of asthma and are experiencing an exacerbation.
✕Probably not a fit
Patients with concurrent chronic obstructive pulmonary disease (COPD) or those unable to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of the AeviceMD Monitoring System in managing asthma by reducing acute exacerbations and improving patient outcomes. It employs a randomized controlled trial design, recruiting 180 patients aged 7 and above, alongside 120 clinicians, over a follow-up period of three months. The study assesses various factors including symptom control, quality of life, self-efficacy, and the usability of the device from both patient and clinician perspectives. The aim is to determine if remote monitoring can enhance disease management and decrease the frequency of asthma attacks.
Why it matters
Potential benefit: If successful, this approach could significantly improve asthma management and reduce the frequency of exacerbations for patients.
How similar studies have gone: Other studies have shown promise in using remote monitoring for chronic respiratory diseases, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of asthma * Pediatric patients (age 7 to 17), adult patients (age 18 and above * Have an asthma exacerbation on the day of visit * Be willing to use the AeviceMD device * Has a smart phone to download the application that is paired with Aevice * Has wireless fidelity (WIFI) connection to use with Aevice * English speaking Exclusion Criteria: * No capacity for consent * Concurrent chronic obstructive pulmonary disease (COPD)
Where it's running
-
SingHealth Polyclinics
Singapore, Singapore Recruiting
Study contacts
- Principal investigator: Mabel QH Leow, PhD — SingHealth Polyclinics
- Study coordinator: Mabel QH Leow, PhD
- Email: mabel.leow.q.h@singhealth.com.sg
- Phone: +65 63507598
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Post-Exacerbation Asthma Telecare
This trial tests whether a structured remote pulmonology follow-up after an asthma flare‑up can reduce repeat exacerbations compared with usual care.
-
ASMact: Managing bronchial asthma attacks in children
This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.
-
Boosting referrals to asthma specialists after an ER visit
This study tests whether arranging a telehealth follow-up with an asthma specialist from the ER helps adults with asthma see a specialist within 3 months more often than usual referrals.
-
45th Multicenter Airway Collaboration on ED initiation of Airsupra
This trial tests whether giving Airsupra in the emergency department reduces asthma recurrence over three months for adults sent home on a short course of steroids.
-
Nebulized ketamine added to standard care for moderate to severe asthma attacks
In adults with moderate to severe asthma attacks, this study tests whether inhaled ketamine given with standard treatment helps breathing better than standard treatment alone.
-
Personalized asthma treatment in primary care.
This study will try inhaled corticosteroids used as-needed (R-ICS), azithromycin, or both to see if they reduce asthma exacerbations in people aged 13–75 with persistent asthma in primary care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.